These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 29587241)
1. Butyrate, a dietary fiber derivative that improves irinotecan effect in colon cancer cells. Encarnação JC; Pires AS; Amaral RA; Gonçalves TJ; Laranjo M; Casalta-Lopes JE; Gonçalves AC; Sarmento-Ribeiro AB; Abrantes AM; Botelho MF J Nutr Biochem; 2018 Jun; 56():183-192. PubMed ID: 29587241 [TBL] [Abstract][Full Text] [Related]
2. Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention. Zeng H; Hamlin SK; Safratowich BD; Cheng WH; Johnson LK Nutr Res; 2020 Nov; 83():63-72. PubMed ID: 33017771 [TBL] [Abstract][Full Text] [Related]
3. Wheat Bran for Colon Cancer Prevention: The Synergy between Phytochemical Alkylresorcinol C21 and Intestinal Microbial Metabolite Butyrate. Zhao Y; Shi L; Hu C; Sang S J Agric Food Chem; 2019 Nov; 67(46):12761-12769. PubMed ID: 31675233 [TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models. Na YS; Jung KA; Kim SM; Hong YS; Ryu MH; Jang SJ; Moon DH; Cho DH; Kim JC; Lee JS; Kim TW Cancer Chemother Pharmacol; 2011 Aug; 68(2):389-98. PubMed ID: 21046105 [TBL] [Abstract][Full Text] [Related]
5. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Thangaraju M; Cresci GA; Liu K; Ananth S; Gnanaprakasam JP; Browning DD; Mellinger JD; Smith SB; Digby GJ; Lambert NA; Prasad PD; Ganapathy V Cancer Res; 2009 Apr; 69(7):2826-32. PubMed ID: 19276343 [TBL] [Abstract][Full Text] [Related]
6. Inflammation-Modulating Effect of Butyrate in the Prevention of Colon Cancer by Dietary Fiber. Chen J; Vitetta L Clin Colorectal Cancer; 2018 Sep; 17(3):e541-e544. PubMed ID: 29866614 [TBL] [Abstract][Full Text] [Related]
7. Acetylcarnitine potentiates the anticarcinogenic effects of butyrate on SW480 colon cancer cells. Elimrani I; Dionne S; Saragosti D; Qureshi I; Levy E; Delvin E; Seidman EG Int J Oncol; 2015 Aug; 47(2):755-63. PubMed ID: 26043725 [TBL] [Abstract][Full Text] [Related]
8. In vitro studies on the inhibition of colon cancer by butyrate and carnitine. Roy MJ; Dionne S; Marx G; Qureshi I; Sarma D; Levy E; Seidman EG Nutrition; 2009; 25(11-12):1193-201. PubMed ID: 19619983 [TBL] [Abstract][Full Text] [Related]
9. Butyrate production from high-fiber diet protects against lymphoma tumor. Wei W; Sun W; Yu S; Yang Y; Ai L Leuk Lymphoma; 2016 Oct; 57(10):2401-8. PubMed ID: 26885564 [TBL] [Abstract][Full Text] [Related]
10. Synergistic efficacy of 3n-butyrate and 5-fluorouracil in human colorectal cancer xenografts via modulation of DNA synthesis. Bras-Gonçalves RA; Pocard M; Formento JL; Poirson-Bichat F; De Pinieux G; Pandrea I; Arvelo F; Ronco G; Villa P; Coquelle A; Milano G; Lesuffleur T; Dutrillaux B; Poupon MF Gastroenterology; 2001 Mar; 120(4):874-88. PubMed ID: 11231942 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Scharlau D; Borowicki A; Habermann N; Hofmann T; Klenow S; Miene C; Munjal U; Stein K; Glei M Mutat Res; 2009; 682(1):39-53. PubMed ID: 19383551 [TBL] [Abstract][Full Text] [Related]
12. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280 [TBL] [Abstract][Full Text] [Related]
13. Butyrate-mediated acquisition of chemoresistance by human colon cancer cells. Kang HR; Choi HG; Jeon CK; Lim SJ; Kim SH Oncol Rep; 2016 Aug; 36(2):1119-26. PubMed ID: 27277338 [TBL] [Abstract][Full Text] [Related]
14. Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells. Serpa J; Caiado F; Carvalho T; Torre C; Gonçalves LG; Casalou C; Lamosa P; Rodrigues M; Zhu Z; Lam EW; Dias S J Biol Chem; 2010 Dec; 285(50):39211-23. PubMed ID: 20926374 [TBL] [Abstract][Full Text] [Related]
15. Escape from negative regulation of growth by transforming growth factor beta and from the induction of apoptosis by the dietary agent sodium butyrate may be important in colorectal carcinogenesis. Hague A; Manning AM; van der Stappen JW; Paraskeva C Cancer Metastasis Rev; 1993 Sep; 12(3-4):227-37. PubMed ID: 8281610 [TBL] [Abstract][Full Text] [Related]
17. The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38. LaBonte MJ; Manegold PC; Wilson PM; Fazzone W; Louie SG; Lenz HJ; Ladner RD Int J Cancer; 2009 Dec; 125(12):2957-69. PubMed ID: 19536776 [TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Hague A; Manning AM; Hanlon KA; Huschtscha LI; Hart D; Paraskeva C Int J Cancer; 1993 Sep; 55(3):498-505. PubMed ID: 8397167 [TBL] [Abstract][Full Text] [Related]
19. Resistance to butyrate impairs bile acid-induced apoptosis in human colon adenocarcinoma cells via up-regulation of Bcl-2 and inactivation of Bax. Barrasa JI; Santiago-Gómez A; Olmo N; Lizarbe MA; Turnay J Biochim Biophys Acta; 2012 Dec; 1823(12):2201-9. PubMed ID: 22917577 [TBL] [Abstract][Full Text] [Related]
20. Revisit dietary fiber on colorectal cancer: butyrate and its role on prevention and treatment. Encarnação JC; Abrantes AM; Pires AS; Botelho MF Cancer Metastasis Rev; 2015 Sep; 34(3):465-78. PubMed ID: 26224132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]